Availability of antigen-presenting cells can determine the extent of CD4 effector expansion and priming for secretion of Th2 cytokines in vivo.

MLA

Bradley, Linda M., et al. “Availability of Antigen-Presenting Cells Can Determine the Extent of CD4 Effector Expansion and Priming for Secretion of Th2 Cytokines in Vivo.” European Journal of Immunology, vol. 32, no. 8, Aug. 2002, pp. 2338–46. EBSCOhost, https://doi.org/10.1002/1521-4141(200208)32:8<2338::AID-IMMU2338>3.0.CO;2-R.

APA

Bradley, L. M., Harbertson, J., Biederman, E., Zhang, Y., Bradley, S. M., & Linton, P.-J. (2002). Availability of antigen-presenting cells can determine the extent of CD4 effector expansion and priming for secretion of Th2 cytokines in vivo. European Journal of Immunology, 32(8), 2338–2346. https://doi.org/10.1002/1521-4141(200208)32:8<2338::AID-IMMU2338>3.0.CO;2-R

Chicago

Bradley, Linda M, Judith Harbertson, Elana Biederman, Yu Zhang, Scott M Bradley, and Phyllis-Jean Linton. 2002. “Availability of Antigen-Presenting Cells Can Determine the Extent of CD4 Effector Expansion and Priming for Secretion of Th2 Cytokines in Vivo.” European Journal of Immunology 32 (8): 2338–46. doi:10.1002/1521-4141(200208)32:8<2338::AID-IMMU2338>3.0.CO;2-R.